ORF18 - Late-Breaking Oral Abstract/Rapid-Fire I

ORF Chair-Primary(s)

• 

  George Stamatiades, MD, PhD

  Instructor
  Medicine
  BRIGHAM AND WOMEN'S HOSPITAL
  Boston, MA, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 3:30 PM - 3:35 PM CT

  The Flavanol Gallocatechin as a Novel Therapeutic Candidate for Thyroid Eye Disease by Mitigating Pathological Remodeling in Orbital fibroblasts
  

  Submitting author: Xuhui Li, Dr. – The First Affiliated Hospital, Sun Yat-sen University

  Rapid and Poster Presenter: Xuhui Li, Dr. – The First Affiliated Hospital, Sun Yat-sen University

  Co-Author: Yan Guo, MD, PhD – The First Affiliated Hospital, Sun Yat-sen University

  Senior Author/Primary Investigator: Yanbing Li, MD, PhD – The First Affiliated Hospital, Sun Yat-sen University
• 3:35 PM - 3:40 PM CT

  A Three-Variable Diagnosis-Stage Screening Model to Differentiate Wolfram Syndrome from Type 1 Diabetes: A Single-Centre Study with Decision Curve Analysis
  

  Submitting author: Anna Alieva, MD, PhD, DSc – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology

  Rapid and Poster Presenter: Anna Alieva, MD, PhD, DSc – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology

  Co-Author: Nasiba Alimova, PhD – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology

  Co-Author: Zebo Salikhova, Ms – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology

  Co-Author: Sevara Anvarova, Ms – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology

  Co-Author: Shakhrizoda Sultanova, Dr – Republican Specialized Scientific-and-Practical Medical Centre of Endocrinology
• 3:40 PM - 3:45 PM CT

  Skeletal Muscle, Adipocyte, and Hepatocyte-Autonomous Roles of the Activin Type II Receptors in the Regulation of Body Weight During Obesity
  

  Submitting author: Elizabeth Nunn – University of Pennsylvania

  Rapid and Poster Presenter: Elizabeth Nunn – University of Pennsylvania

  Co-Author: Álbert S. Peixoto, PhD – University of Sao Paolo

  Co-Author: Dominic Santoleri, PhD – University of Pennsylvania

  Co-Author: Haihong Guo, MS – Eli Lilly and Company

  Co-Author: John Le Lay, PhD – Eli Lilly and Company

  Co-Author: Matthew Gavin, n/a – University of Pennsylvania

  Co-Author: Megan Stefkovich, PhD – University of Pennsylvania

  Co-Author: Joseph A. Baur, PhD – University of Pennsylvania

  Senior Author/Primary Investigator: Paul M. Titchenell, PhD – Eli Lilly and Company
• 4:00 PM - 4:15 PM CT

  A Novel TSHR Blocking Antibody Effectively Reduces Hyperthyroidism and Proptosis in a Mouse Model of Graves' and Thyroid Eye Disease
  

  Submitting author: Mutayyaba Adnan, MPH – REGENERON PHARM INC

  Oral Abstract Presenter: Mutayyaba Adnan, MPH – REGENERON PHARM INC

  Co-Author: Santiago Mendez-Huergo, PhD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Marilena Preda, MSRIS – Regeneron Pharmaceuticals, Inc.

  Co-Author: Leigh Spencer Noakes, PhD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Matthew Marzelli, MS – Regeneron Pharmaceuticals, Inc.

  Co-Author: Gustavo Gimenez, MS – Regeneron Pharmaceuticals, Inc.

  Co-Author: Anass Agrud, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: Mary Germino, PhD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Johnathon Walls, PhD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Guillermo Lehmann, MD, PhD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Bristol Denlinger, Ph.D. – REGENERON PHARM INC

  Senior Author/Primary Investigator: Botir Sagdullaev, PhD – Regeneron Pharmaceuticals, Inc.